IRIS
CUCINELLA, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 305
EU - Europa 171
AS - Asia 113
OC - Oceania 2
AF - Africa 1
Totale 592
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 300
IE - Irlanda 109
CN - Cina 94
IT - Italia 22
SG - Singapore 19
FI - Finlandia 17
SE - Svezia 8
DE - Germania 5
PT - Portogallo 5
CA - Canada 4
AU - Australia 2
BE - Belgio 2
GB - Regno Unito 1
MX - Messico 1
NG - Nigeria 1
NL - Olanda 1
RU - Federazione Russa 1
Totale 592
Salva come PNG Salva come JPEG
Città #
Dublin 109
Chandler 85
Beijing 22
Boardman 19
Nanjing 17
Ashburn 15
Shanghai 14
Lawrence 13
Princeton 13
Helsinki 12
Medford 12
Singapore 12
New York 11
Changsha 8
Jacksonville 8
Nanchang 8
Hebei 7
Stockholm 7
Wilmington 7
Chicago 6
Shenyang 6
Jiaxing 5
Austin 4
Menlo Park 4
Fairfield 3
Hangzhou 3
Houston 3
Milan 3
Palermo 3
Udine 3
Vila Nova de Gaia 3
Ann Arbor 2
Brussels 2
Buguggiate 2
Dallas 2
Marystown 2
Montreal 2
Mouriz 2
Norwalk 2
Pavia 2
Redwood City 2
Seattle 2
Sydney 2
Amsterdam 1
Asaba 1
Benito Juarez 1
Biddeford 1
Falkenstein 1
Gallarate 1
Gatchina 1
Ningbo 1
Orange 1
Piscataway 1
Pordenone 1
Rozzano 1
Taizhou 1
Tianjin 1
Turin 1
Totale 484
Salva come PNG Salva come JPEG
Nome #
Advances in pharmacotherapy for treating female sexual dysfunction 62
Has flibanserin revolutionized the treatment of hypoactive sexual desire disorder or is there still room for more effective therapeutics? 53
Modulation of nociceptive threshold by combined hormonal contraceptives in women with oestrogen-withdrawal migraine attacks: a pilot study 51
Medical Treatment of Female Sexual Dysfunction 47
Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL) 46
Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women 44
Modulation of nociceptive threshold by combined hormonal contraceptives in women with oestrogen-withdrawal migraine attacks: a pilot study 42
Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading? 41
Sexuality in premature ovarian insufficiency 39
The role of hormone therapy in urogenital health after menopause 36
Viewing symptoms associated with Vulvovaginal Atrophy (VVA)/Genitourinary syndrome of menopause (GSM) through the estro-androgenic lens – Cluster analysis of a web-based Italian survey among women over 40 34
Sexuality, pelvic floor/vaginal health and contraception at menopause 32
Biallelic mutations in PSMC3IP are associated with secondary amenorrhea: expanding the spectrum of premature ovarian insufficiency 27
Menopause and female sexual dysfunctions (FSDs) 22
Relationship between personality traits and sexual function in symptomatic postmenopausal women 18
Epidemiological transitions in a life-course perspective: challenges and opportunities for healthy ageing 15
Different local estrogen therapies for a tailored approach to GSM 10
Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Current Perspectives on the Role of Laser Therapy 4
Totale 623
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.110
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 2 1 3 0 1 15 0
2020/202115 0 0 0 1 2 0 0 6 4 1 0 1
2021/202249 0 1 0 0 0 0 0 4 2 1 14 27
2022/2023273 22 25 0 8 27 22 0 16 128 0 18 7
2023/2024118 12 23 2 10 6 23 9 3 4 3 5 18
2024/202550 25 22 3 0 0 0 0 0 0 0 0 0
Totale 623